Myriad Genetics, Inc. (MYGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$4.31
+1.41%
Mkt Cap $408.02M
Analyst Ratings
Buy
0
Hold
4
Sell
0
Price Target (17 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+39.2%
Consensus $6.00 vs current $4.31